🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

European Stocks Mixed; Deutsche Telekom Shines, AstraZeneca Slips

Published 11/12/2021, 03:47 AM
Updated 11/12/2021, 03:48 AM
© Reuters.
EUR/USD
-
UK100
-
XAU/USD
-
FCHI
-
DE40
-
CFR
-
GC
-
LCO
-
CL
-
TMUS
-
AZN
-
JD
-
BABA
-
DTEGY
-
HLAG
-

By Peter Nurse 

Investing.com - European stock markets traded in a mixed fashion Friday, searching for direction following the sharp rise in U.S. inflation yet generally positive corporate earnings.

At 3:50 AM ET (0850 GMT), the DAX in Germany traded 0.1% higher, the CAC 40 in France rose 0.2%, climbing to a new record high, while the U.K.’s FTSE 100 dropped 0.3%.

The main European indices look set to post a positive week, helped by the overall strength of the quarterly earnings season in Europe and despite a surprisingly strong reading on U.S. inflation, which raised the possibility of the Federal Reserve bringing forward plans to lift interest rates.  

The U.S. consumer price index rose 6.2% year-on-year in October, official data showed on Wednesday, the strongest advance since November 1990.

Helping the tone were gains in Asia overnight, aided by signs of consumer confidence as Chinese e-commerce giants Alibaba (NYSE:BABA) and JD (NASDAQ:JD).com set new sales records across their platforms on Singles Day, the world's largest shopping event.

Back in Europe, Deutsche Telekom (OTC:DTEGY) stock rose 1.6% after reporting core profit above market estimates, raising its full-year outlook for the third time, boosted by its U.S. unit T-Mobile (NASDAQ:TMUS), along with growth in European business.

Richemont (SIX:CFR) stock soared 8.4% after the Swiss luxury goods group reported a healthy jump in its net profit in the first half of its fiscal year, and outlined plans to revamp its loss-making Yoox-Net-a-Porter business.

Hapag Lloyd (DE:HLAG) stock rose 4.7% after the German container shipping line reported a more than 10-fold surge in nine-month net profit. 

On the flip side, AstraZeneca (NASDAQ:AZN) stock fell 2.4% despite the drugmaker expecting its Covid-19 vaccine to move to "modest profitability" on new orders after posting $1.05 billion in vaccine sales for the third quarter. The company has said will not make a profit from the drug during the pandemic.

The European economic calendar centers around Eurozone industrial production data for September, while the U.K. and the European Union are due to enter new negotiations over trade arrangements in Northern Ireland, in an attempt to avoid a potential trade war.

Crude prices weakened Friday, weighed by the continued strength of the U.S. dollar which makes the commodity more expensive for non-U.S. buyers.

The release of the Baker Hughes rig count and CFTC positioning data round off a volatile week in the oil market, while eyes will also be on Glasgow as the U.N. climate summit enters its final day. 

By 3:50 AM ET, U.S. crude futures traded 1% lower at $80.75 a barrel, while the Brent contract fell 0.8% to $82.19. Both contracts are on course to record losses of around 0.7% this week.

Additionally, gold futures fell 0.5% to $1,855.45/oz, while EUR/USD traded largely unchanged at 1.1451.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.